Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reisa Sperling

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2025
Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension studyChristopher H van Dyck, Reisa Sperling, Keith Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2025
Five years of the Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD)Joshua D Grill, Margaret D Mastrolorenzo, Heather M Snyder, et al.
Research Square|May 19, 2025
Localization of Network-Level Atrophy in Preclinical Alzheimer's DiseaseSoyoung Lee, Sheena Baratono, Grace Burt, et al.
JAMA Network Open|July 6, 2021
Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease TrialRema Raman, Yakeel T Quiroz, Oliver Langford, et al.
JAMA Neurology|September 23, 2016
Tau Positron Emission Tomographic Imaging in the Lewy Body DiseasesStephen N Gomperts, Joseph J Locascio, Sara J Makaretz, et al.
The Journal of Clinical Investigation|August 5, 2003
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer diseaseAlon Monsonego, Victor Zota, Arnon Karni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 31, 2022
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's diseaseOskar Hansson, Rebecca M Edelmayer, Adam L Boxer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidencePaul Aisen, Randall J Bateman, Damian Crowther, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Genome-wide scan of Flortaucipir PET levels finds <i>JARID2</i> associated with cerebral tau depositionTamil Iniyan Gunasekaran, Devendra Meena, Annie J Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Functional MRI detection of pharmacologically induced memory impairmentReisa Sperling, Douglas Greve, Anders Dale, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2025
Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension studyChristopher H van Dyck, Reisa Sperling, Keith Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2025
Five years of the Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD)Joshua D Grill, Margaret D Mastrolorenzo, Heather M Snyder, et al.
Research Square|May 19, 2025
Localization of Network-Level Atrophy in Preclinical Alzheimer's DiseaseSoyoung Lee, Sheena Baratono, Grace Burt, et al.
JAMA Network Open|July 6, 2021
Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease TrialRema Raman, Yakeel T Quiroz, Oliver Langford, et al.
JAMA Neurology|September 23, 2016
Tau Positron Emission Tomographic Imaging in the Lewy Body DiseasesStephen N Gomperts, Joseph J Locascio, Sara J Makaretz, et al.
The Journal of Clinical Investigation|August 5, 2003
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer diseaseAlon Monsonego, Victor Zota, Arnon Karni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 31, 2022
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's diseaseOskar Hansson, Rebecca M Edelmayer, Adam L Boxer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidencePaul Aisen, Randall J Bateman, Damian Crowther, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Genome-wide scan of Flortaucipir PET levels finds <i>JARID2</i> associated with cerebral tau depositionTamil Iniyan Gunasekaran, Devendra Meena, Annie J Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Functional MRI detection of pharmacologically induced memory impairmentReisa Sperling, Douglas Greve, Anders Dale, et al.
Pageof 10